The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
DLH HLDGS CORP COM 23335Q100 57 21,977 SH   OTR   21,977 0 0
ECHO THERAPEUTICS INC COM NEW 27876L906 1,414 831,883 SH   OTR   831,883 0 0
INSPIREMD INC COM NEW 45779A309 7 24,453 SH   OTR   24,453 0 0
NAVIDEA BIOPHARMACEUTICALS I COM 63937X103 19,630 12,192,327 SH   OTR   12,192,327 0 0
NAVIDEA BIOPHARMACEUTICALS I CALL 63937X103 9,821 6,100,000 SH Call OTR   6,100,000 0 0
PEDEVCO CORP COM NEW 70532Y204 1,674 3,719,444 SH   OTR   3,719,444 0 0
VIRCO MFG CO COM 927651109 125 43,799 SH   OTR   43,799 0 0